Overview

Enfusion is an institutional investment operations platform for hedge funds and asset managers running strategies from long/short equity to multi-asset. It is best suited to teams that need portfolio, trading, compliance, and risk workflows connected in one system. Its breadth is a strong fit for complex operations, but custom pricing and client-provided access equipment make it less suited to firms seeking a ready-priced, turnkey app.

Clearwater says Enfusion serves more than 1,000 hedge funds and asset managers in over 30 countries. The platform supports both asset coverage categories, investor reporting, and multiple currencies.

For category comparisons, browse Portfolio Management Software and Investment Accounting Software.

Key features

Portfolio operations and execution

Real-time positions, P&L, analytics, and factor exposure give portfolio teams a current view of holdings and risk. Orders can be generated from model changes or target exposure adjustments, connecting portfolio decisions to execution. The native order and execution management system supports equities, fixed income, options, futures, FX, swaps, and other instruments.

FIX connectivity to more than 300 liquidity sources, along with automated prime broker and custodian delivery, can reduce manual handoffs for firms with broad trading and reporting flows. This connectivity is most relevant to managers with multiple counterparties, rather than teams whose needs stop at portfolio monitoring.

Controls, data, and risk

Pre-trade checks run during order creation and can apply firm, client, and regulatory rules. Custom rules and warning, note, or hard-block severity levels let a firm calibrate intervention, from a prompt to a stop on an order. IBOR and ABOR share one database, supported by a security master of more than four million instruments maintained by Enfusion.

Risk tools cover what-if scenarios, live factor exposure, Greeks, DV01, implied volatility, yields, credit spreads, and post-trade factor attribution. Firms can also plug in proprietary or third-party factor models, including Axioma, alongside Clearwater's GR8 model. That breadth supports teams evaluating exposures across varied instruments, though the platform is not a substitute for investment or legal advice.

Service and responsibilities

Customers receive secure, user-permissioned access and dedicated account-manager support, with help by phone and email. Managed services use the same cloud-native platform and draw on a team of more than 200 operations professionals, a potentially useful option for firms that want operational support alongside software.

Clients must provide the hardware, software, internet bandwidth, and related equipment required for access. Enfusion's terms also require annual risk assessments, logical and physical access controls, documented incident response, and breach notification where feasible within 72 hours. The company states that it is not a broker-dealer or investment adviser and does not provide accounting, tax, financial, investment, or legal advice.

Pricing

Enfusion is paid software with custom pricing. The Enfusion by Clearwater plan has no published price; prospective clients can request a demo with no commitment or contract required. Without a published tier structure, buyers should assess cost directly against their operating scope rather than assume a standard seat or usage allowance.

Platforms

Enfusion supports web access and downloads for Windows, Mac, Linux, and iOS. That range gives investment teams desktop and browser options, with iOS access for supported mobile workflows. Android is not among the supported platforms.

Who it's for

Enfusion is aimed at hedge funds and asset managers whose needs span portfolio accounting, trading, compliance, risk analysis, and investor reporting. Its instrument coverage, multi-currency support, and counterparty connectivity make it a stronger fit for complex institutional workflows than for individuals or firms looking for a narrow portfolio tracker. The need to supply access equipment and obtain custom pricing also favors organizations able to evaluate a substantial operational platform.

Pros and cons

Broad investment workflow coverage: Portfolio management, native execution, pre-trade compliance, risk analytics, and reporting sit within one platform.
Extensive trading connectivity: FIX links to more than 300 liquidity sources, with automated prime broker and custodian delivery.
Flexible controls and risk models: Custom compliance rules can warn or block, while proprietary and third-party factor models can be integrated.
Custom pricing requires a sales step: There is no published price to compare before requesting a demo.
Clients carry access requirements: Firms must supply the equipment and sufficient internet bandwidth needed to use the platform.
Not an advisory service: Enfusion does not provide investment, accounting, tax, financial, or legal advice.

Alternatives

For buyers comparing adjacent paid platforms, Juniper Square, WealthSpectrum, Dynamo CRM & Deal Management, FinFolio, Asset Vantage, Orion Portfolio Accounting, Black Diamond Wealth Solutions, and FIS Data Integrity Manager are other options; their listed platforms vary across web, mobile, API, self-hosted, or web-only access.

Asset Vantage publishes a few plan details: AV Aspire includes 10 dashboards, AV PRO covers up to five entities, and SFO - 10 Entities costs 30000.00 USD per year, billed annually. Orion Portfolio Accounting's Foundation plan starts at 13000.00 USD per year and includes billing and reporting, Orion Planning, a client portal, and a mobile app. Those are useful reference points for buyers who want a stated annual price or plan scope; Enfusion instead offers custom pricing.

Dynamo CRM & Deal Management offers ballpark pricing via demo request. Buyers considering it can compare its CRM and deal-management focus with Enfusion's broader investment operations scope. The other alternatives may be worth comparing when their paid platform approach aligns with a buyer's requirements.

Verdict

Enfusion is a compelling choice for hedge funds and asset managers that need portfolio oversight, execution, controls, risk analytics, and reporting tied together across complex strategies. Its main reason to choose is the breadth of connected investment workflows; its main reason to look elsewhere is the combination of custom pricing and client responsibility for access infrastructure. Teams that need a narrower tool, a published price, or a different platform mix should compare alternatives before committing.

	Allocare AMS	Enfusion
Free plan	No	No
Free trial	No	No
Paid from	—	—
Open source	No	No
Platforms	—	iOS, Linux, macOS, Web, Windows
Asset class coverage	multi_asset_alternatives	—
Performance reporting	Yes	Yes
Allocation analysis	Yes	—
Risk analysis	Yes	—

Allocare AMS vs Enfusion

Allocare AMS

Enfusion